January 26, 2021
Reducing Complexity in Starting Clinical Trials: More Patients, Faster Startup
1:00 p.m. – 2:00 p.m. EST

We will explore how our collaboration:

• Reduces study startup cycle times by harmonizing processes and common documents across studies;
• Automates workflows for the management of contacting sites and collecting site documentation for IRB/EC submissions;
• And more.
  

January 27, 2021
Medical Device Clinical Trials in China: Latest Regulatory Developments
11:00 a.m. – 12:30 p.m. EST

Webinar Takeaways:

• Different clinical pathways and how to decide which pathway to choose to support the National Medical Products Administration (NMPA) medical device/in vitro diagnostic (IVD) regulatory submission or postmarket surveillance;
• Key areas you need to pay attention to so as to have the right strategy and tactics to shorten clinical trials and approval times;
• Whether your devices qualify for the real-world data/study Hainan program and how to get into the program;
• And more.